[Pneumocystis carinii pneumonia in patients with connective tissue diseases].
The First Department of Internal Medicine University of Occupational & Environmental Health, School of Medicine.
Kazuyoshi
K
Saito
Yoshiya
Y
Tanaka
D000890:Anti-Infective Agents / Q000627:therapeutic use; D003240:Connective Tissue Diseases / Q000150:complications*; D004359:Drug Therapy, Combination; D006801:Humans; D025202:Molecular Diagnostic Techniques; D009894:Opportunistic Infections / Q000150:complications*; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D016133:Polymerase Chain Reaction; D011239:Prednisolone / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000890:Anti-Infective Agents; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011239:Prednisolone